Earlier this month, the Ontario Veterinary College (OVC) hosted a first-of-its-kind event that brought together a diverse group of people united by a shared commitment to fighting osteosarcoma. Patients, survivors, dog owners, researchers, graduate students and advocates gathered at the University of Guelph Arboretum for the inaugural patient-partner meeting of DOGBONe, the Dog Osteosarcoma Group – Biomarkers of Neoplasia.
The event offered a unique opportunity to connect those personally affected by osteosarcoma with the researchers working to advance treatments for both people and pets.
“Osteosarcoma is a rare and aggressive bone cancer that primarily affects children and young adults—Terry Fox being one of the most well-known cases,” says Dr. Geoffrey Wood, professor and osteosarcoma researcher at OVC. “In dogs, especially large and giant breeds, this type of cancer is over 10 times more common than in people. At the genetic and clinical levels, the cancer is nearly identical in both species. This biological similarity creates a powerful opportunity to advance research that benefits both species.”
“In the past decade, advancements in cancer biology, engineering and clinical trials have led to the discovery of genetic markers that are helping us better understand how the disease progresses,” says Dr. Alicia Viloria-Petit, professor and osteosarcoma researcher at OVC.
Osteosarcoma survivors Molly and Kara Skrubis
Osteosarcoma survivors Molly and Vinesha Ramasamy
Through DOGBONe, a multidisciplinary research initiative co-led by Wood and Viloria-Petit, this work is now moving toward earlier and more accurate diagnostic tests—bringing hope for better outcomes in both human and veterinary medicine. DOGBONe brings together experts across veterinary and human health to accelerate discoveries that improve lives on both ends of the leash. This vital research is generously supported by OVC Pet Trust and the Ontario Institute for Cancer Research.
Throughout the event at the U of G Arboretum Centre, participants heard from a wide range of voices. OVC researchers Drs. Wood, Viloria-Petit and Anthony Mutsaers joined Dr. Douglas Thamm of Colorado State University to share the latest in osteosarcoma research.
These scientific presentations were woven together with powerful personal stories: Vinesha Ramasamy, an Ontario-based survivor and educator; Kara Skrubis, a dancer, osteosarcoma survivor and a Social Media Manager for MIB Agents, a nonprofit organization that supports families affected by osteosarcoma through education and advocacy; Christina Ip-Toma, mother of Dylan, who passed away from osteosarcoma and MIB Agents Scientific Director; and dog owners Kun Huo and Barclay Cantin, who spoke about their dogs, Milo and Molly—both osteosarcoma survivors.
For many, the most moving part of the day was hearing directly from those impacted by osteosarcoma. Their stories—honest, emotional, and brave—brought the science to life and reminded everyone why this work matters.
The event closed with a group photo and outdoor activities, offering a heartfelt reminder that this is not just about research—it’s about real lives and real futures.
To everyone who took part—thank you. Your presence, your perspectives, and your partnership are what make this work possible. Together, we’re fighting osteosarcoma—one discovery, one life, one story at a time.
Source: University of Guelph